Mirriam Domocos

I completed my undergraduate degree in Applied Medical Sciences at University College London UCL in June 2024, after graduating from the higher-level technical high school for chemistry in Vienna, AT (HBLVA17 Rosensteingasse) specializing in biochemistry and molecular biotechnology. During my time at UCL, I discovered my fascination with neuroscience, genetics, cell and developmental biology, and epigenetics, particularly their involvement in neurodegenerative diseases. Thanks to my degree, I acquired an extensive understanding of the pathophysiology of various diseases and can link these processes to laboratory experiments and biochemistry. Moreover, I worked at the Feinstein Institutes for Medical Research of Northwell Health in New York with Dr Yun Freudenberg-Hue, Dr Luca Giliberto, and Dr Cristina D’Abramo on Alzheimer’s Disease and tauopathies over the summer of 2023. My research project investigated the pathogenic effect of various mutations within the microtubule-associated protein tau (MAPT) in primary tauopathies such as frontotemporal dementia. Besides, I have also conducted various research projects across different fields, covering cancer research, pharmacology, immunology, allergy research, and women’s health at the Medical University of Vienna and UCL. In October 2024, I joined the group of Dr Mootaz Salman to start my Master of Science by Research in Physiology, Anatomy, and Genetics specializing in molecular neurodegeneration. My current project focuses on neuroinflammatory signalling pathways of the blood-brain barrier (BBB) that lead to neurodegeneration on a 3D microfluidic BBB-on-a-chip model. Further interests of mine include epigenetic changes during neurodegeneration, pharmacoepigenetics, and neuroinflammation. At the University of Oxford, I look forward to getting challenged in my research to expand my skills, mindset, and knowledge and to continue with a PhD.